| JXHB2100002 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs | Supplementary Application | 2021-01-06 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | In Review | 2022-01-20 | view |
| JXHS1900039 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2019-03-25 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2021-07-28 | view |
| JXHS1900038 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2019-03-25 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2021-07-28 | view |
| JXHB2000065 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs(2.4) | Supplementary Application | 2020-12-21 | | AstraZeneca AB | In Review | 2021-05-09 | view |
| JXHB2000064 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs(2.4) | Supplementary Application | 2020-12-21 | | AstraZeneca AB | In Review | 2021-05-09 | view |
| JXHL2100039 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2021-02-03 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | In Review | 2021-02-02 | view |
| JXHL2100038 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2021-02-03 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | In Review | 2021-02-02 | view |
| JXHS2100001 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2021-01-12 | | | In Review | 2021-01-12 | view |
| JXHS2100002 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2021-01-08 | | | In Review | 2021-01-07 | view |
| JXHB2100001 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs | Supplementary Application | 2021-01-06 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | In Review | 2021-01-05 | view |
| JXHB2000049 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs | Supplementary Application | 2020-11-20 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | In Review | 2020-11-20 | view |
| JXHB2000050 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs | Supplementary Application | 2020-11-20 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | In Review | 2020-11-20 | view |
| JXHL2000250 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2020-09-19 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | In Review | 2020-09-18 | view |
| JXHL2000249 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2020-09-19 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | In Review | 2020-09-18 | view |
| JYHB2001071 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs | Supplementary Application | 2020-07-04 | | | Certificate Issued | 2020-09-15 | view |
| JYHB2001072 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs | Supplementary Application | 2020-07-09 | | | Certificate Issued | 2020-09-15 | view |
| JYHB2001609 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2020-08-28 | | | Filed | 2020-09-11 | view |
| JYHB2001608 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2020-08-28 | | | Filed | 2020-09-11 | view |
| JXHL2000113 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2020-05-27 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | In Review | 2020-05-26 | view |
| JXHL2000112 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2020-05-27 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | In Review | 2020-05-26 | view |
